Epaminurad
N/A
Report date: 2026/04/10 20:01:49
NME
Base Information
Drug NameEpaminurad
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJw Pharmaceutical Corp
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesJw Pharmaceutical CorpJiangsu Simcere Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A